Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $1.652B (100.0% shares, 0.0% debt)

Holdings (34)

VTI VANGUARD INDEX FDS 18.2%

Value $301M Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 9.7%

Value $161M Shares 2,798,830 Est. Cost $22.16 Unrealized +68.8%

TEM TEMPUS AI INC 8.3%

Value $138M Shares 4,074,419 Est. Cost $30.66 Unrealized +61.3%

EWTX EDGEWISE THERAPEUTICS INC 8.1%

Value $134M Shares 5,000,000 Est. Cost $17.44 Unrealized +82.6%

ASML ASML HOLDING N V 7.0%

Value $115M Shares 165,836 Est. Cost $662.32 Unrealized —

CRM SALESFORCE INC 5.9%

Value $98.26M Shares 293,901 Est. Cost $193.03 Unrealized +64.1%

RXRX RECURSION PHARMACEUTICALS IN 4.1%

Value $68.37M Shares 10,114,633 Est. Cost $6.72 Unrealized 0.0%

MIRM MIRUM PHARMACEUTICALS INC 3.8%

Value $62.02M Shares 1,500,000 Est. Cost $12.27 Unrealized +239.7%

PCVX VAXCYTE INC 3.7%

Value $61.4M Shares 750,000 Est. Cost $31.07 Unrealized +219.6%

INSM INSMED INC 3.0%

Value $50.03M Shares 724,666 Est. Cost $23.10 Unrealized +211.7%

CRNX CRINETICS PHARMACEUTICALS IN 3.0%

Value $49.1M Shares 960,215 Est. Cost $19.36 Unrealized +188.9%

VRDN VIRIDIAN THERAPEUTICS INC 2.6%

Value $43.13M Shares 2,250,000 Est. Cost $16.80 Unrealized +29.4%

AVBP ARRIVENT BIOPHARMA INC 2.5%

Value $40.51M Shares 1,520,627 Est. Cost $19.60 Unrealized +46.4%

BABA ALIBABA GROUP HLDG LTD 2.3%

Value $38.35M Shares 452,327 Est. Cost $165.09 Unrealized —

PHVS PHARVARIS N V 2.0%

Value $33.07M Shares 1,725,000 Est. Cost $15.26 Unrealized +34.9%

BMRN BIOMARIN PHARMACEUTICAL INC 1.9%

Value $32.21M Shares 490,000 Est. Cost $84.22 Unrealized -20.5%

— MERUS N V 1.9%

Value $31.54M Shares 750,000 Est. Cost $57.72 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 1.5%

Value $25.27M Shares 1,000,000 Est. Cost $37.39 Unrealized -27.3%

— CARGO THERAPEUTICS INC 1.5%

Value $23.99M Shares 1,663,724 Est. Cost $21.33 Unrealized —

FOLD AMICUS THERAPEUTICS INC 1.4%

Value $23.55M Shares 2,500,000 Est. Cost $12.83 Unrealized -19.0%

— LANZATECH GLOBAL INC 1.3%

Value $21.67M Shares 15,814,845 Est. Cost $3.88 Unrealized —

— BLUEPRINT MEDICINES CORP 0.9%

Value $15.26M Shares 175,000 Est. Cost $59.75 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 0.8%

Value $13.83M Shares 1,100,000 Est. Cost $28.09 Unrealized -46.4%

— VERVE THERAPEUTICS INC 0.8%

Value $13.54M Shares 2,400,000 Est. Cost $12.43 Unrealized —

ZBIO ZENAS BIOPHARMA INC 0.8%

Value $13.1M Shares 1,600,000 Est. Cost $17.31 Unrealized -9.9%

CBLL CERIBELL INC. 0.5%

Value $8.51M Shares 328,809 Est. Cost $27.25 Unrealized 0.0%

FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%

Value $8.355M Shares 1,500,000 Est. Cost $17.55 Unrealized -55.3%

LXEO LEXEO THERAPEUTICS INC 0.4%

Value $7.387M Shares 1,122,581 Est. Cost $13.07 Unrealized -39.7%

KYTX KYVERNA THERAPEUTICS INC 0.4%

Value $6.919M Shares 1,850,000 Est. Cost $19.62 Unrealized -75.6%

— MERSANA THERAPEUTICS INC. 0.4%

Value $6.077M Shares 4,250,000 Est. Cost $1.43 Unrealized —

ABCL ABCELLERA BIOLOGICS INC 0.2%

Value $3.302M Shares 1,126,915 Est. Cost $8.47 Unrealized -67.1%

IOBT IO BIOTECH INC 0.2%

Value $3.086M Shares 3,354,449 Est. Cost $6.26 Unrealized -84.1%

MQ MARQETA INC 0.1%

Value $1.674M Shares 441,558 Est. Cost $22.37 Unrealized -80.4%

GLTO GALECTO INC 0.0%

Value $465K Shares 99,913 Est. Cost $13.05 Unrealized -49.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$301M	18.2%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	2,798,830	$161M	9.7%	$22.16	+68.8%	CL A LTD VT SH	11271J107
TEM	TEMPUS AI INC	4,074,419	$138M	8.3%	$30.66	+61.3%	CL A	88023B103
EWTX	EDGEWISE THERAPEUTICS INC	5,000,000	$134M	8.1%	$17.44	+82.6%	COM	28036F105
ASML	ASML HOLDING N V	165,836	$115M	7.0%	$662.32	—	N Y REGISTRY SHS	N07059210
CRM	SALESFORCE INC	293,901	$98.26M	5.9%	$193.03	+64.1%	COM	79466L302
RXRX	RECURSION PHARMACEUTICALS IN	10,114,633	$68.37M	4.1%	$6.72	0.0%	CL A	75629V104
MIRM	MIRUM PHARMACEUTICALS INC	1,500,000	$62.02M	3.8%	$12.27	+239.7%	COM	604749101
PCVX	VAXCYTE INC	750,000	$61.4M	3.7%	$31.07	+219.6%	COM	92243G108
INSM	INSMED INC	724,666	$50.03M	3.0%	$23.10	+211.7%	COM PAR $.01	457669307
CRNX	CRINETICS PHARMACEUTICALS IN	960,215	$49.1M	3.0%	$19.36	+188.9%	COM	22663K107
VRDN	VIRIDIAN THERAPEUTICS INC	2,250,000	$43.13M	2.6%	$16.80	+29.4%	COM	92790C104
AVBP	ARRIVENT BIOPHARMA INC	1,520,627	$40.51M	2.5%	$19.60	+46.4%	COM	04272N102
BABA	ALIBABA GROUP HLDG LTD	452,327	$38.35M	2.3%	$165.09	—	SPONSORED ADS	01609W102
PHVS	PHARVARIS N V	1,725,000	$33.07M	2.0%	$15.26	+34.9%	COM	N69605108
BMRN	BIOMARIN PHARMACEUTICAL INC	490,000	$32.21M	1.9%	$84.22	-20.5%	COM	09061G101
—	MERUS N V	750,000	$31.54M	1.9%	$57.72	—	COM	N5749R100
CLDX	CELLDEX THERAPEUTICS INC NEW	1,000,000	$25.27M	1.5%	$37.39	-27.3%	COM NEW	15117B202
—	CARGO THERAPEUTICS INC	1,663,724	$23.99M	1.5%	$21.33	—	COM	14179K101
FOLD	AMICUS THERAPEUTICS INC	2,500,000	$23.55M	1.4%	$12.83	-19.0%	COM	03152W109
—	LANZATECH GLOBAL INC	15,814,845	$21.67M	1.3%	$3.88	—	COM	51655R101
—	BLUEPRINT MEDICINES CORP	175,000	$15.26M	0.9%	$59.75	—	COM	09627Y109
RCKT	ROCKET PHARMACEUTICALS INC	1,100,000	$13.83M	0.8%	$28.09	-46.4%	COM	77313F106
—	VERVE THERAPEUTICS INC	2,400,000	$13.54M	0.8%	$12.43	—	COM	92539P101
ZBIO	ZENAS BIOPHARMA INC	1,600,000	$13.1M	0.8%	$17.31	-9.9%	COM	98937L105
CBLL	CERIBELL INC.	328,809	$8.51M	0.5%	$27.25	0.0%	COM	15678C102
FDMT	4D MOLECULAR THERAPEUTICS IN	1,500,000	$8.355M	0.5%	$17.55	-55.3%	COM	35104E100
LXEO	LEXEO THERAPEUTICS INC	1,122,581	$7.387M	0.4%	$13.07	-39.7%	COM	52886X107
KYTX	KYVERNA THERAPEUTICS INC	1,850,000	$6.919M	0.4%	$19.62	-75.6%	COM	501976104
—	MERSANA THERAPEUTICS INC.	4,250,000	$6.077M	0.4%	$1.43	—	COM	59045L106
ABCL	ABCELLERA BIOLOGICS INC	1,126,915	$3.302M	0.2%	$8.47	-67.1%	COM	00288U106
IOBT	IO BIOTECH INC	3,354,449	$3.086M	0.2%	$6.26	-84.1%	COM	449778109
MQ	MARQETA INC	441,558	$1.674M	0.1%	$22.37	-80.4%	CLASS A COM	57142B104
GLTO	GALECTO INC	99,913	$465K	0.0%	$13.05	-49.9%	COM NEW	36322Q206